OR WAIT null SECS
December 16, 2020
John Rim, the company’s former executive vice-president, has been named its new president and CEO.
December 15, 2020
The companies are entering into a license and collaboration agreement for the development and commercialization of Relay’s investigational cancer treatment, RLY-1971, a potent inhibitor of SHP2, a molecule that plays a role in cancer cell survival.
The company will expand its clinical supply chain services by establishing two new facilities in Rheinfelden and Weil am Rhein, Germany.
Freezers, shipping containers, and tracking systems aid distribution of COVID-19 vaccines.
Through the acquisition, Eli Lilly will have access to Prevail’s portfolio of clinical-stage and preclinical neuroscience assets.
Sterling Pharma Solutions has formed a new strategic partnership with ADC Bio.
December 14, 2020
The company will expand the site to include six new containment isolators and a product development manufacturing laboratory.
December 11, 2020
The European Commission has granted a license for the use of inclisiran (Leqvio) as a treatment of primary hypercholesterolemia or mixed dyslipidaemia in adult patients.
Celltrion Healthcare has announced that EMA's CHMP has issued a positive opinion for the marketing authorization of CT-P17—an adalimumab biosimilar.
The Vaccines Manufacturing and Innovation Centre (VMIC) has chosen Lonza’s MODA-EM solution for the digitalization of its microbiology quality control operations.